once a week glp 1 agonist Emergency Medicine Ottawa | π¨ GLP-1 agonists are everywhere in the ED now. Ozempic, Wegovy, Mounjaro and friends are changing Emergency Medicine, from gastroparesis Current Insights, Advantages and Challenges
Description
Leave-one-out sensitivity analyses confirmed the direction and magnitude of the AUD finding but highlighted the limited evidence base for hospitalization

Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects

A 2024 RCT found semaglutide reduced hip bone density by 2.6% and lumbar spine by 2.1% in one year

Treatment results vary from person to person

GIP Receptor Antagonism (Blocking): Unlike many dual-agonists that activate GIP, MariTide blocks it

In this review, we aimed to summarize the changes in endogenous GLP-1 levels and their association with weight loss after MBS, describe the effects of GLP-1-RA use on weight loss after MBS, and emphasize metabolic adaptations in light of the recent literature
